Merck & Co. said its second-quarter earnings surged thanks to a one-time gain that masked a modest decline in revenue. The pharmaceutical company raised the low end of its per-share earnings estimate for the year.
from WSJ.com: US Business http://ift.tt/1Atu1u9
via IFTTT
from WSJ.com: US Business http://ift.tt/1Atu1u9
via IFTTT
No comments:
Post a Comment